BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31313827)

  • 1. Safety and efficacy of transarterial embolization of hepatocellular adenomas.
    van Rosmalen BV; Klompenhouwer AJ; de Graeff JJ; Haring MPD; de Meijer VE; Rifai L; Dokmak S; Rawashdeh A; Abu Hilal M; de Jong MC; Dejong CHC; Doukas M; de Man RA; IJzermans JNM; van Delden OM; Verheij J; van Gulik TM;
    Br J Surg; 2019 Sep; 106(10):1362-1371. PubMed ID: 31313827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of transarterial embolization for hepatocellular adenomas.
    van Rosmalen BV; Coelen RJS; Bieze M; van Delden OM; Verheij J; Dejong CHC; van Gulik TM
    Br J Surg; 2017 Jun; 104(7):823-835. PubMed ID: 28518415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and outcome of hepatocellular adenoma with massive bleeding at presentation.
    Klompenhouwer AJ; de Man RA; Thomeer MG; Ijzermans JN
    World J Gastroenterol; 2017 Jul; 23(25):4579-4586. PubMed ID: 28740346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective study on timing of resection of hepatocellular adenoma.
    Klompenhouwer AJ; Bröker MEE; Thomeer MGJ; Gaspersz MP; de Man RA; IJzermans JNM
    Br J Surg; 2017 Nov; 104(12):1695-1703. PubMed ID: 28857134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hepatocellular adenoma: comparison of resection, embolization and observation.
    Karkar AM; Tang LH; Kashikar ND; Gonen M; Solomon SB; Dematteo RP; D' Angelica MI; Correa-Gallego C; Jarnagin WR; Fong Y; Getrajdman GI; Allen P; Kingham TP
    HPB (Oxford); 2013 Mar; 15(3):235-43. PubMed ID: 23374365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective transcatheter arterial embolization for treatment of bleeding complications or reduction of tumor mass of hepatocellular adenomas.
    Erdogan D; van Delden OM; Busch OR; Gouma DJ; van Gulik TM
    Cardiovasc Intervent Radiol; 2007; 30(6):1252-8. PubMed ID: 17605070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disappearance of Hepatocellular Adenoma in a Patient with Cornelia de Lange Syndrome after Treatment with Transcatheter Arterial Embolization.
    Takata K; Kitaguchi T; Tokushige H; Nagata T; Miyayama T; Shibata K; Fukuda H; Yamauchi R; Fukunaga A; Tanaka T; Yokoyama K; Shakado S; Yoshimitsu K; Kusano H; Sakisaka S; Hirai F
    Intern Med; 2024 Jun; 63(11):1569-1573. PubMed ID: 37866915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
    Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
    BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Model to Predict Regression of Large Size Hepatocellular Adenoma.
    Klompenhouwer AJ; Alblas M; van Rosmalen BV; Haring MPD; Venema E; Doukas M; Thomeer MGJ; Takkenberg RB; Verheij J; de Meijer VE; van Gulik TM; Lingsma HF; de Man RA; Ijzermans JNM
    Am J Gastroenterol; 2019 Aug; 114(8):1292-1298. PubMed ID: 30920416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embolization of renal angiomyolipomas: short-term and long-term outcomes, complications, and tumor shrinkage.
    Lee SY; Hsu HH; Chen YC; Huang CC; Wong YC; Wang LJ; Chuang CK; Yang CW
    Cardiovasc Intervent Radiol; 2009 Nov; 32(6):1171-8. PubMed ID: 19572171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard.
    Massarweh NN; Davila JA; El-Serag HB; Duan Z; Temple S; May S; Sada YH; Anaya DA
    J Surg Res; 2016 Feb; 200(2):552-9. PubMed ID: 26507276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Hepatocellular Adenoma: Recent Advances.
    Agrawal S; Agarwal S; Arnason T; Saini S; Belghiti J
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1221-30. PubMed ID: 24909909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes After Transarterial Embolization of Neuroendocrine Tumor Liver Metastases Using Spherical Particles of Different Sizes.
    Zener R; Yoon H; Ziv E; Covey A; Brown KT; Sofocleous CT; Thornton RH; Boas FE
    Cardiovasc Intervent Radiol; 2019 Apr; 42(4):569-576. PubMed ID: 30627774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres.
    Osuga K; Hori S; Hiraishi K; Sugiura T; Hata Y; Higashihara H; Maeda N; Tomoda K; Nakamura H
    Cardiovasc Intervent Radiol; 2008; 31(6):1108-16. PubMed ID: 18543028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
    Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
    World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Life-saving therapy for haemorrhaging liver adenomas using selective arterial embolization.
    Stoot JH; van der Linden E; Terpstra OT; Schaapherder AF
    Br J Surg; 2007 Oct; 94(10):1249-53. PubMed ID: 17696216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and natural history of hepatocellular adenomas: the impact of obesity.
    Bunchorntavakul C; Bahirwani R; Drazek D; Soulen MC; Siegelman ES; Furth EE; Olthoff K; Shaked A; Reddy KR
    Aliment Pharmacol Ther; 2011 Sep; 34(6):664-74. PubMed ID: 21762186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transarterial Embolization for Treatment of Symptomatic Polycystic Liver Disease: More than 2-year Follow-up.
    Zhang JL; Yuan K; Wang MQ; Yan JY; Xin HN; Wang Y; Liu FY; Bai YH; Wang ZJ; Duan F; Fu JX
    Chin Med J (Engl); 2017 Aug; 130(16):1938-1944. PubMed ID: 28776546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and Prognostic Factors in Patients with Spontaneously Ruptured Hepatocellular Carcinoma.
    Matsumoto T; Chung H; Suginoshita Y; Ito K; Inokuma T
    Hepatogastroenterology; 2015 Jun; 62(140):942-6. PubMed ID: 26902033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resection, transplantation and local regional therapies for liver adenomas.
    Dokmak S; Cauchy F; Belghiti J
    Expert Rev Gastroenterol Hepatol; 2014 Sep; 8(7):803-10. PubMed ID: 24957321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.